{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Another Outbreak! Monkeypox 2022 Infection and Vaccine Considerations for the Clinical Nurse Specialist

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the clinical manifestations of monkeypox.
  2. Select the transmission precautions applicable to monkeypox.
  3. Choose the information to give patients prior to administering a monkeypox vaccine.

Learning Outcomes

Seventy-five percent of participants will demonstrate competency in clinical reasoning regarding the prevention and assessment of monkeypox by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $21.95


  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Test Code: CNS1122
Published: Nov/Dec 2022
Expires: 12/6/2024
Required Passing Score: 8/10 (80%)
Authors: Patricia Anne O'Malley, PhD, APRN-CNS